If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


 
MADRYN ASSET MANAGEMENT, LP
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
 
MADRYN HEALTH PARTNERS II, LP
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
 
MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
 
MADRYN HEALTH ADVISORS II, LP
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
 
MADRYN HEALTH ADVISORS GP II, LLC
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
 
MADRYN SELECT OPPORTUNITIES, LP
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
 
MADRYN SELECT ADVISORS, LP
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
 
MADRYN SELECT ADVISORS GP, LLC
 
Signature:/s/ Matthew Girandola
Name/Title:Matthew Girandola / Chief Compliance Officer
Date:08/12/2025
Comments accompanying signature:
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named above agree to the joint filing on behalf of each of them of this Statement on Schedule 13D with respect to the Common Stock.